Patents by Inventor David DeVos

David DeVos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11744863
    Abstract: Process for preparing a heat-treated pooled human platelet lysate, said process comprising the steps of: a) Providing a pooled human platelet lysate (p HPL), b) Heat-treating the pooled human platelet lysate at a temperature of 50° C. to 70° C. during 20 to 40 minutes, c) Purifying the heat-treated pooled human platelet lysate of step b).
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: September 5, 2023
    Assignees: Centre Hospitalier Regional et Universitaire De Lille (CHRU), UNIVERSITE DE LILLE 2 DROIT ET SANTE, UNIVERSITE DU LITTORAL COTE D'OPALE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), TAIPEI MEDICAL UNIVERSITY
    Inventors: David Devos, Thierry Burnouf, Jean-christophe Devedjian, Ming-Li Chou, Flore Gouel
  • Publication number: 20230258637
    Abstract: The present invention relates to methods for detecting a target in a sample using mutated nanobodies, wherein an amino acid present in the loop of the FR1 region of framework of the nanobodies is mutated to cysteine.
    Type: Application
    Filed: October 12, 2021
    Publication date: August 17, 2023
    Inventors: Sabine SZUNERITS, Alain ROUSSEL, Christian CAMBILLAU, David DEVOS, Ilka ENGELMAN, Enagnon Kazali ALIDJINOU
  • Publication number: 20230135837
    Abstract: The present invention relates on a process for preparing platelet lysate fraction, said process comprising the steps of: 1) providing a platelet lysate, 2) collecting from said platelet lysate a fraction wherein the components exhibit a maximum molecular weight of 100 kDa, on a specific platelet lysate fraction and its use as a drug.
    Type: Application
    Filed: September 27, 2018
    Publication date: May 4, 2023
    Inventors: David DEVOS, Thierry BURNOUF, Jean-christophe DEVEDJIAN, Ming-Li CHOU, Flore GOUEL
  • Publication number: 20200113942
    Abstract: Process for preparing a heat-treated pooled human platelet lysate, said process comprising the steps of: a) Providing a pooled human platelet lysate (p HPL), b) Heat-treating the pooled human platelet lysate at a temperature of 50° C. to 70° C. during 20 to 40 minutes, c) Purifying the heat-treated pooled human platelet lysate of step b).
    Type: Application
    Filed: June 15, 2018
    Publication date: April 16, 2020
    Inventors: David DEVOS, Thierry BURNOUF, Jean-christophe DEVEDJIAN, Ming-Li CHOU, Flore GOUEL
  • Publication number: 20190099448
    Abstract: A process for preparing a modified heat-treated platelet pellet lysate, said process comprising the steps of: a) Providing a platelet pellet lysate, b) Heat-treating the platelet pellet lysate at a temperature of 55° C. to 65° C. during 20 to 40 minutes, c) Purifying the heat-treated platelet pellet lysate of step b) so as to obtain a modified heat treated platelet pellet lysate having a total protein content of less than 70% of the total protein content of the platelet pellet lysate of step a).
    Type: Application
    Filed: March 23, 2017
    Publication date: April 4, 2019
    Inventors: David DEVOS, Thierry BURNOUF, Jean-christophe DEVEDJIAN, Ming-Li CHOU
  • Publication number: 20190022034
    Abstract: The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 24, 2019
    Inventors: David Devos, Caroline Moreau, Charlotte Laloux, Jean-Christophe Devedjian
  • Patent number: 10105326
    Abstract: The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its formulation to its administration.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: October 23, 2018
    Assignees: Centre Hospitalier Regional Et Universitaire De Lille (Chru), Universite De Lille 2 Droit Et Sante, Universite Du Littoral Cote D'Opale
    Inventors: David Devos, Caroline Moreau, Charlotte Laloux, Jean-christophe Devedjian
  • Publication number: 20170151193
    Abstract: The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its firmation to its administration.
    Type: Application
    Filed: May 12, 2015
    Publication date: June 1, 2017
    Inventors: David Devos, Caroline Moreau, Charlotte Laloux, Jean-christophe Devedjian
  • Publication number: 20100126066
    Abstract: A modular green roof system includes: a bottom layer including a porous structure such that water may pass through the bottom layer; a silt management layer adjacent to the bottom layer; an insulation layer adjacent to the silt management layer; a water retention layer adjacent to the insulation layer, a growth media layer adjacent to the water retention layer; a biodegradable layer including plant seed adjacent to the growth media layer; a top layer including a porous structure such that water and sunlight may pass through the top layer, wherein the top layer and the bottom layer form a perimeter within which the silt management layer, the water retention layer, the growth media layer and the biodegradable layer are contained; and a plurality of thickness controllers spaced intermittently such that the distance between the bottom layer and the top layer is limited by the thickness controllers.
    Type: Application
    Filed: November 20, 2009
    Publication date: May 27, 2010
    Inventor: David DeVos